Teva-Kowa Accelerates Japanese Generic Expansion With Taisho Acquisition
This article was originally published in PharmAsia News
Executive Summary
Teva-Kowa Pharma announced Dec. 24 it will purchase a majority stake in mid-size generic competitor Taisho Pharmaceutical Industries. The acquisition gives the joint venture immediate access to 220 generic products and 50 sales staff